AbbVie (ABBV) Work In Process (2012 - 2016)

AbbVie (ABBV) has 5 years of Work In Process data on file, last reported at $1.1 billion in Q2 2016.

• Quarterly Work In Process rose 4.81% year-over-year to $1.1 billion in Q2 2016, while the trailing twelve-month figure through Jun 2016 was $1.1 billion (up 4.81% YoY) and the FY2015 annual result came in at $1.1 billion, up 71.86% from the prior year.
• Work In Process declined to $1.1 billion in Q2 2016 per ABBV's latest filing, from $1.1 billion in the prior quarter.
• Across five years, Work In Process topped out at $1.1 billion in Q1 2016 and bottomed at $262.0 million in Q1 2013.
• The 5-year median for Work In Process is $568.0 million (2015), against an average of $672.0 million.
• The widest annual swing landed in 2015, when Work In Process soared 122.85%; it then increased 4.81% in 2016.
• Tracing ABBV's Work In Process over 5 years: stood at $286.0 million in 2012, then surged by 41.26% to $404.0 million in 2013, then surged by 55.69% to $629.0 million in 2014, then surged by 71.86% to $1.1 billion in 2015, then retreated by 1.2% to $1.1 billion in 2016.
• Per Business Quant, the three latest ABBV Work In Process figures stand at $1.1 billion (Q2 2016), $1.1 billion (Q1 2016), and $1.1 billion (Q4 2015).

Peer Comparison